Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001144204-15-031663
Filing Date
2015-05-15
Accepted
2015-05-15 16:31:48
Documents
2
Effectiveness Date
2015-05-15

Document Format Files

Seq Description Document Type Size
1 DEFA14A v410892_defa14a.htm DEFA14A 30516
2 GRAPHIC timage.jpg GRAPHIC 1059
  Complete submission text file 0001144204-15-031663.txt   33466
Mailing Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854
Business Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854 732-980-4500
ENZON PHARMACEUTICALS INC (Filer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36435 | Film No.: 15870064
SIC: 2836 Biological Products, (No Diagnostic Substances)